These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30235288)

  • 41. Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.
    Manning PM; Hamilton G; Wang K; Park C; Hooker JC; Wolfson T; Gamst A; Haufe WM; Schlein AN; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Mar; 42(3):833-841. PubMed ID: 27688063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photon-counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Lin H; Xu X; Deng R; Xu Z; Cai X; Dong H; Yan F
    Radiology; 2024 Sep; 312(3):e240038. PubMed ID: 39315897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.
    Deng J; Fishbein MH; Rigsby CK; Zhang G; Schoeneman SE; Donaldson JS
    Pediatr Radiol; 2014 Nov; 44(11):1379-87. PubMed ID: 24840769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of field inhomogeneity map following magnitude-based ambiguity-resolved water-fat separation.
    Triay Bagur A; McClymont D; Hutton C; Borghetto A; Gyngell ML; Aljabar P; Robson MD; Brady M; Bulte DP
    Magn Reson Imaging; 2023 Apr; 97():102-111. PubMed ID: 36632946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-examination agreement between multi-echo gradient echo and confounder-corrected chemical shift-encoded MR sequences for R2* estimation as a biomarker of liver iron content in patients with a wide range of T2*/R2* and proton density fat fraction values.
    Moura Cunha G; Kolokythas O; Chen W; Akcicek H; Hitt D; Briller NE; Amin K
    Abdom Radiol (NY); 2023 Jul; 48(7):2302-2310. PubMed ID: 37055586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
    Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
    Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
    Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
    Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
    Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
    Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and evaluation of quantitative MRI phantoms to mimic the simultaneous presence of fat, iron, and fibrosis in the liver.
    Zhao R; Hamilton G; Brittain JH; Reeder SB; Hernando D
    Magn Reson Med; 2021 Feb; 85(2):734-747. PubMed ID: 32783200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    Campo CA; Hernando D; Schubert T; Bookwalter CA; Pay AJV; Reeder SB
    AJR Am J Roentgenol; 2017 Sep; 209(3):592-603. PubMed ID: 28705058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Agreement and Reproducibility of Proton Density Fat Fraction Measurements Using Commercial MR Sequences Across Different Platforms: A Multivendor, Multi-Institutional Phantom Experiment.
    Jang JK; Lee SS; Kim B; Cho ES; Kim YJ; Byun JH; Park BJ; Kim SY; Kim JH
    Invest Radiol; 2019 Aug; 54(8):517-523. PubMed ID: 30913055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique.
    Mahlke C; Hernando D; Jahn C; Cigliano A; Ittermann T; Mössler A; Kromrey ML; Domaska G; Reeder SB; Kühn JP
    J Magn Reson Imaging; 2016 Dec; 44(6):1425-1431. PubMed ID: 27197806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiating supraclavicular from gluteal adipose tissue based on simultaneous PDFF and T
    Franz D; Diefenbach MN; Treibel F; Weidlich D; Syväri J; Ruschke S; Wu M; Holzapfel C; Drabsch T; Baum T; Eggers H; Rummeny EJ; Hauner H; Karampinos DC
    J Magn Reson Imaging; 2019 Aug; 50(2):424-434. PubMed ID: 30684282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton Density Fat Fraction Measurements at 1.5- and 3-T Hepatic MR Imaging: Same-Day Agreement among Readers and across Two Imager Manufacturers.
    Serai SD; Dillman JR; Trout AT
    Radiology; 2017 Jul; 284(1):244-254. PubMed ID: 28212052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload.
    İdilman İS; Gümrük F; Haliloğlu M; Karçaaltıncaba M
    Turk J Haematol; 2016 Mar; 33(1):21-7. PubMed ID: 26376710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing breast density using the chemical-shift encoding-based proton density fat fraction in 3-T MRI.
    Borde T; Wu M; Ruschke S; Boehm C; Stelter J; Weiss K; Metz S; Makowski MR; Karampinos DC; Fallenberg EM
    Eur Radiol; 2023 Jun; 33(6):3810-3818. PubMed ID: 36538074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.
    Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB;
    Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fat spectral modeling on triglyceride composition quantification using chemical shift encoded magnetic resonance imaging.
    Simchick G; Yin A; Yin H; Zhao Q
    Magn Reson Imaging; 2018 Oct; 52():84-93. PubMed ID: 29928937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.